Clinical Trial: Study to Evaluate the Performance of the INSTI(R) HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904403) titled 'Study to Evaluate the Performance of the INSTI(R) HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection' on Oct. 22.

Brief Summary: A multicenter prospective study to evaluate the clinical performance, usability, and contrived result interpretation of the INSTI(R) HCV Antibody Test (INSTI HCV) with fingerstick (FS) whole blood specimens from participants with signs or symptoms of hepatitis or participants at risk for hepatitis C infection, by trained operators at point of care (POC) settings. POC settings are locations where medical diagnostic testing i...